611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
High Rate of Anemia Seen After Weight-Loss SurgeryHighest Adverse Effect Rates for Three Drugs in Parkinson'sThyroid Surgery for Benign Goiters Ups Quality of LifeSteroid Injection Betters Hand Function With Carpal TunnelSound the Mosquito Alarm, Across the USAAsthma Drug Tied to Nightmares, DepressionCould Pests, Dust Lower Kids' Odds for Asthma?Health Tip: Prevent Carbon Monoxide PoisoningInflammatory Bowel Disease May Raise Cancer Risk in KidsUltrasound Echo Intensity Is Potential Frailty BiomarkerDrone Sets New Record for Transporting Blood SamplesGeneral, Central Obesity Linked to Specific Breast Cancer RiskProton Pump Inhibitors Overused WorldwideWeight-Loss Surgery May Leave Some AnemicHealth Tip: Four Common Types Of AcneOne-Quarter of Lupus Patients Have Metabolic SyndromeKids' Colds Linked to Asthma, Lung Problems LaterMetabolomic Profiles Differ With Macular DegenerationExtended Thromboprophylaxis Safe, Effective After Liver SurgeryExercise May Stem Kidney Damage in Lupus PatientsMinorities Exposed to Dirtier Air, U.S. Study FindsDoctors Eye the Danger From 'Nerf' GunsHealth Tip: Preventing Food Allergies While Dining OutIt's a Food Allergy! Where's the School Nurse?Lower Mortality Risk Seen With Statin Use in Older MenSleep Quality, Duration Linked to CKD ProgressionSelena Gomez's Kidney Transplant Puts Lupus Center StageVision Problems Common in Babies Infected With ZikaSmoking, Poor Diet Lead Global Death CausesWhich Single Behavior Best Prevents High Blood Pressure?Traces of Tattoo May Reach the Lymph NodesVitamin D Deficiency Tied to Neuropathic Pain'Upside' to Diabetes Really Isn'tSemen Harbors Wide Range of VirusesHeath Tip: Contact Lenses Aren't Risk-FreeDiabetes Threatens Kidneys, Vision of Millions of AmericansNew Guideline Aims to Help Doctors Diagnose Head, Neck Masses'Microbiomes' May Hold Key to Kids' Ear InfectionsWarfarin, Rivaroxaban Similarly Safe, EffectiveHealth Tip: Leading Causes of Food PoisoningER Visits for These 3 Health Woes Don't Have to Happen'Modest at Best' Discriminatory Ability for CBC Test in InfantsDo E-Cigarettes Damage Blood Vessels?'Healthy' Obese Still Face Higher Heart RisksTake a Stand Against Sitting Too MuchGreater Height Tied to Higher Risk of Venous ThromboembolismZika Virus Preferentially Targets Glioblastoma Stem CellsBiomarkers Can Predict Rapid Drop in Renal Function in T2DMPeople Picking Up Infection From Pet Store Puppies' Poop: CDCHeath Tip: Getting Rid of Head Lice
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

FDA Approves Endari for the Treatment of Sickle Cell Disease


HealthDay News
Updated: Jul 10th 2017

new article illustration

MONDAY, July 10, 2017 (HealthDay News) -- The U.S. Food and Drug Administration has approved Endari (L-glutamine oral powder) to treat patients with sickle cell disease.

Approval of Endari was based on a clinical trial that included patients aged 5 to 58 with sickle cell disease who had two or more painful crises within the 12 months before enrollment in the trial. During the 48-week study, patients who received the drug had fewer hospital visits for pain treated with a narcotic or ketorolac than those who received a placebo (median of three versus four). They also had fewer hospitalizations for sickle cell pain (median of two versus three), and fewer days in the hospital (median of 6.5 versus 11 days). Patients who received Endari also had a lower risk of acute chest syndrome than those who received a placebo (8.6 versus 23.1 percent).

Common side effects of Endari included constipation, nausea, headache, abdominal pain, cough, pain in the extremities, back pain, and chest pain, according to the FDA.

"Endari is the first treatment approved for patients with sickle cell disease in almost 20 years," Richard Pazdur, M.D., acting director of the Office of Hematology and Oncology Products at the FDA's Center for Drug Evaluation and Research, said in a statement. "Until now, only one other drug was approved for patients living with this serious, debilitating condition."

More Information